$Ionis Pharmaceuticals(IONS)$$Arrowhead Pharmaceuticals(ARWR)$ $Alnylam Pharmaceuticals(ALNY)$ 🚨 $IONS Q2 2026: Pipeline Shock Overshadows a Massive Commercial Opportunity ⚠️📉 Ionis delivered one of the most polarising biotech reports of the quarter. Commercial execution remains impressive, with DAWNZERA continuing to gain momentum and TRYNGOLZA now approved for the much larger severe hypertriglyceridaemia (sHTG) market. However, enthusiasm was overshadowed by a major setback after the Phase 3 CARDIO-TTRansform study for eplontersen failed to meet its primary endpoint in the overall ATTR-CM population, removing one of the company’s most ant
$Corning(GLW)$$Amphenol(APH)$ $TE Connectivity(TEL)$ 🚨 Corning $GLW Just Posted Strong Earnings. So Why Is the Stock Getting Crushed? 📉👀 Today’s move has caught many traders off guard. 🔻 Pacing for its worst single-session decline since March 2020 📊 RSI has fallen to 28, entering oversold territory 📈 Options volume surged to roughly 3x normal levels within the first hour, with traders aggressively buying both downside puts and upside August calls. Despite the sell-off: 🟢 EPS: $0.78 vs $0.75 expected 🟢 Revenue: $4.74B vs $4.63B expected CEO Wendell Weeks remained highly confident: “We continue to deepen our long-term customer partnerships with
$HBT Financial, Inc.(HBT)$$First Busey(BUSE)$ $Old Second(OSBC)$ 🚀 $HBT Q2 2026 Earnings: Merger Synergies Ignite Profit Growth as Margins Outperform Regional Banking Peers HBT Financial delivered a standout first full quarter following its CNB Bank acquisition, demonstrating that disciplined integration can rapidly translate into stronger profitability. Net Income surged to $27.8 million, or $0.76 per share, from an acquisition-impacted $11.2 million in Q1. Net Interest Income climbed 22.5% sequentially, while Net Interest Margin (NIM) expanded 12 basis points to an impressive 4.32%, bucking the trend of margin pressure across many regional
$GE Vernova Inc.(GEV)$$Eaton Corp PLC(ETN)$ $Emerson(EMR)$ $GEV Q2 2026: $176B Backlog Signals an AI Infrastructure Supercycle ⚡🚀 $GEV now holds an astonishing $176B backlog (+37% YoY), with 116 GW of gas turbine orders and reservations effectively filling manufacturing capacity through 2027. Management says the power industry is still only in the early stages of a multi-decade growth opportunity, while customers paying years in advance to secure scarce manufacturing slots demonstrates extraordinary pricing power. With AI data centres demanding reliable electricity now, gas turbines have become one of the fastest paths to dispatchable power. O
$Tesla Motors(TSLA)$$Microsoft(MSFT)$ $Alphabet(GOOGL)$ 🚨 Options Frenzy: $TSLA, $MSFT and $NVDA Lead as Earnings Season Heats Up 📈🔥 Options activity is exploding as earnings season shifts into top gear, with AI, mega-cap tech and EVs dominating trader attention. Microsoft $MSFT is one of the most interesting setups. Despite falling after 6 of its last 8 earnings reports, options traders remain overwhelmingly bullish. Its 50-day call/put ratio sits above 96% of all readings over the past year, showing traders continue to position for upside despite recent post-earnings weakness. Top 10 Stocks by 10-Day Options Volume: 🥇 $NVDA: 35.89M 🥈 $TS
$Charles Schwab(SCHW)$$JPMorgan Chase(JPM)$ $Goldman Sachs(GS)$ 🚀💰 $SCHW Delivers a Blockbuster Q2! Record Revenue, 42% EPS Growth and NIM Breaks 3.0% 📈🔥 $SCHW delivered one of its strongest quarters in years, putting the cash-sorting bear thesis firmly in the rear-view mirror. Record revenue, accelerating client asset growth, expanding Net Interest Margin (NIM) and continued product innovation demonstrate that Schwab’s earnings engine is firing on multiple cylinders. At a glance: ✅ Record net revenue: $7.1B, up 21% YoY ✅ Adjusted EPS: $1.62, up 42% YoY ✅ Core net new assets (NNA): $120B ✅ June core NNA: $62.7B ✅ NIM: 3.00% ✅ Client assets: Ov
$AMC Entertainment(AMC)$$GameStop(GME)$ 🎬 $AMC Q2 Earnings: 106-Year Record Revenue, EBITDA Explodes 70%, But Is Dilution Still the Villain? 🍿📈 $AMC Q2 2026 earnings: Record Top-Line Triggers Massive Operating Leverage, But GAAP Losses Persist. 🔸 Record Quarter: Delivered the highest quarterly revenue and Adjusted EBITDA in the company’s 106-year history. AMC delivered its highest quarterly revenue ($1.6B) and Adjusted EBITDA ($321.4M) in its 106-year history. The results strongly validate management’s core thesis: the company’s massive fixed-cost base creates powerful operating leverage when the box office recovers. A 14% YoY revenue increase translated into a remarkable 70% surge in Adjusted E
$Taiwan Semiconductor Manufacturing(TSM)$$Advanced Micro Devices(AMD)$ $NVIDIA(NVDA)$ 🚨 $TSM Options Traders Bet Wrong? AI Growth Outlook Jumps Above 40% 🚀📈 The options market turned aggressively bearish heading into $TSM earnings. 📉 10-day put/call volume ratio surged to the 98th percentile of the past year. 📉 The stock is on pace for 6 consecutive down days and is now 14% below its June record high. 📈 Despite the recent pullback, shares remain up 36% YTD. Then TSMC delivered one of its strongest quarters ever. 🟢 EPS: $4.31 vs $3.94 expected 🟢 Revenue: $40.2B vs $39.3B expected The biggest surprise wasn’t the earnings beat. It was management
$Rocket Lab USA, Inc.(RKLB)$$Kratos Defense & Security Solutions(KTOS)$ $SpaceX(SPCX)$ 🚀 $RKLB Ready for Liftoff? Options May Be Pricing This One Wrong 📈🌕🚀 The options pit may be underestimating $RKLB. Rocket Lab is flashing one of its strongest historical setups: • SVI: 96% • SVS: 87/100 The stock is now testing its 200-day moving average following a sharp July pullback. History suggests this has been a high-probability opportunity. The last five times this signal appeared: ✅ Higher one month later 80% of the time 📈 Average 30-day gain: +37.1% What’s particularly interesting is that Rocket Lab has repeatedly exceeded options traders’ i